Nexgel, Inc.

NXGL Nasdaq SEC CIK 1468929
Follow Nexgel Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $3.2M +8.4% vs same quarter last year
Net income −$1.1M −70.3% vs same quarter last year
EPS, diluted -
Operating cash flow −$32K +95.9% vs same quarter last year
Revenue by quarter
$3M
$2.8M
$2.9M
$2.9M
$2.8M
$2.7M
$3.7M
$3.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income9 fiscal years
  • Revenue
  • Net income
−$5M$0$5M$10M$15MFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$11.4M−$3M
FY24$8.7M−$3.3M
FY23$4.1M−$3.2M
FY22$2M−$4.7M
FY21$1.6M−$4.3M
FY20$674K−$2.3M
FY19$717K−$1.9M
FY18$2.2M−$1.9M
FY17--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−400%−300%−200%−100%0%100%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2539.5%−29.3%−26.3%
FY2431.6%−40.9%−37.8%
FY239.1%−85%−77.2%
FY2212.5%−163.5%−231.7%
FY210.5%−165.7%−277.9%
FY20−43.2%−335.3%−335.9%
FY19−19.1%−268.3%−268.2%
FY1823.2%−85.3%−85.3%
FY17---
Free cash flowOperating cash flow minus capital expenditure
−$6M−$4M−$2M$0FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$1.4M
FY24−$4.3M
FY23−$3.9M
FY22−$3.1M
FY21−$3M
FY20−$2.1M
FY19−$1.8M
FY18-
FY17-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Nexgel
  • Healthcare median
−400%−300%−200%−100%0%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNexgelHealthcare median
FY25−26.3%−30.6%
FY24−37.8%−47%
FY23−77.2%−58%
FY22−231.7%−80.4%
FY21−277.9%−71.8%
FY20−335.9%−62.2%
FY19−268.2%−46.2%
FY18−85.3%−49.6%
FY17-−45.9%